Quantitative Breast Density in Contrast-Enhanced Mammography.
Gisella GennaroMelissa L HillElisabetta BezzonFrancesca CaumoPublished in: Journal of clinical medicine (2021)
Contrast-enhanced mammography (CEM) demonstrates a potential role in personalized screening models, in particular for women at increased risk and women with dense breasts. In this study, volumetric breast density (VBD) measured in CEM images was compared with VBD obtained from digital mammography (DM) or tomosynthesis (DBT) images. A total of 150 women who underwent CEM between March 2019 and December 2020, having at least a DM/DBT study performed before/after CEM, were included. Low-energy CEM (LE-CEM) and DM/DBT images were processed with automatic software to obtain the VBD. VBDs from the paired datasets were compared by Wilcoxon tests. A multivariate regression model was applied to analyze the relationship between VBD differences and multiple independent variables certainly or potentially affecting VBD. Median VBD was comparable for LE-CEM and DM/DBT (12.73% vs. 12.39%), not evidencing any statistically significant difference (p = 0.5855). VBD differences between LE-CEM and DM were associated with significant differences of glandular volume, breast thickness, compression force and pressure, contact area, and nipple-to-posterior-edge distance, i.e., variables reflecting differences in breast positioning (coefficient of determination 0.6023; multiple correlation coefficient 0.7761). Volumetric breast density was obtained from low-energy contrast-enhanced spectral mammography and was not significantly different from volumetric breast density measured from standard mammograms.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- diffusion weighted
- diffusion weighted imaging
- magnetic resonance
- computed tomography
- deep learning
- optical coherence tomography
- polycystic ovary syndrome
- convolutional neural network
- type diabetes
- adipose tissue
- single molecule
- pregnant women
- high resolution
- glycemic control
- pregnancy outcomes
- metabolic syndrome
- skeletal muscle